InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Stankovic Srdjan R., Directeur Comptable. Director active across 1 company, notably Acadia Pharmaceuticals INC. Aggregated, 9 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €48k. History available since 23 February 2022. The latest transaction was filed on 21 November 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Stankovic Srdjan R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
1,847 shares@ US$15.0755.6% of flowCommon StockSEC:0001209191-22-058391:1
6,250 sharesCommon StockSEC:0001209191-22-058391:0
1,326 shares@ US$15.8144.4% of flowCommon StockSEC:0001209191-22-054027:1
2,969 sharesCommon StockSEC:0001209191-22-054027:0
9,616 sharesCommon StockSEC:0001209191-22-026940:0
4,919 shares0Common StockSEC:0001209191-22-013275:0
5,444 sharesCommon StockSEC:0001209191-22-002749:0
6,250 sharesCommon StockSEC:0001209191-21-066570:0
2,969 sharesCommon StockSEC:0001209191-21-060958:0
9 of 9 declarations
About Stankovic Srdjan R.
Stankovic Srdjan R. is Directeur Comptable and President at Acadia Pharmaceuticals INC. Across the 9 filings on record, the sampled recent filings run from 2021-10-19 to 2022-11-22, with 48441 € in sales and 0 € in purchases, and the most common transaction nature is Levée d'options.
